Arana Therapeutics
HOME

Corporate Partners

A key part of the Arana Therapeutics business strategy is the establishment of strategic alliances to both secure new product opportunities and continue the ongoing development of our product pipeline.

For information on our Corporate Partners please use the links below.


Aveo Pharmaceuticals Inc.

Oct 2007
Deal: Superhumanisation™ Technology licensing (up to 5 targets)
Commercial agreement: Upfront, milestones, royalties


Vegenics

Mar 2007
Deal: Single project humanisation/optimisation of flagship product
Commercial agreement: Upfront, milestones, royalties


CSL Limited

Jun 2006
Deal: Multiple humanisation/optimisation projects
1 project completed, approved, 2 projects in progress
Commercial agreement: Upfront, milestones, royalties


GlaxoSmithKline

Oct 2005
Deal: Up to 3 optimisation projects 1st project completed and approved Commercial agreement: upfront, milestones, royalties


Centocor

Nov 2004
Deal: Arana TNF Patent Estate
Commercial agreement: Licensing income


Abbott

Dec 2003
Deal: Arana TNF Patent Estate
Commercial agreement: Licensing income

Arana takes no responsibility for information accessed on 3rd party sites.